Journal article
Isoform composition of antithrombin in a covalent antithrombin–heparin complex
Abstract
Antithrombin (AT) circulates in two isoforms, alpha- (90-95%) and beta-AT (5-10%). AT inhibits clotting factors such as thrombin and factor Xa, a reaction catalyzed by heparin. Heparin has been used in many clinical situations but suffers from limitations such as a short intravenous half-life, bleeding risk, and the inability to inhibit thrombin bound to fibrin clots. In order to overcome some of heparin's limitations, we prepared a covalent …
Authors
Chan AKC; Berry LR; Paredes N; Parmar N
Journal
Biochemical and Biophysical Research Communications, Vol. 309, No. 4, pp. 986–991
Publisher
Elsevier
Publication Date
October 2003
DOI
10.1016/j.bbrc.2003.08.109
ISSN
0006-291X